Suggestions
Matthew Dowling
Chief Scientific Officer at Medcura, Inc.
Matthew Dowling, Ph.D., serves as the Chief Scientific Officer and Director at Medcura, Inc. He completed his undergraduate studies in Chemical Engineering at the University of Notre Dame and earned his doctorate in Bioengineering from the University of Maryland (UMD), where he was awarded the Fischell Fellowship in Biomedical Engineering for his innovative work in drug delivery systems.
At Medcura, Dowling has played a pivotal role in developing a novel biomaterial platform known as gel-e, which focuses on bleeding management solutions. His leadership has contributed to securing over $10 million in non-dilutive grants, resulting in five FDA clearances, two Breakthrough Device Designations, and the issuance of 28 patents along with more than ten peer-reviewed publications in high-impact journals. His work has also garnered attention from various media outlets, including the BBC program "Brave New World with Stephen Hawking" .124
In addition to his scientific contributions, Dowling is recognized for his entrepreneurial spirit and strong work ethic, qualities that have been highlighted in his professional network .3
